Aigen Investment Management LP Makes New Investment in PACS Group, Inc. (NYSE:PACS)

Aigen Investment Management LP bought a new position in PACS Group, Inc. (NYSE:PACS) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 30,534 shares of the company’s stock, valued at approximately $400,000.

Several other institutional investors also recently modified their holdings of the stock. Wellington Management Group LLP increased its holdings in shares of PACS Group by 60.5% in the third quarter. Wellington Management Group LLP now owns 5,376,551 shares of the company’s stock valued at $214,901,000 after buying an additional 2,025,835 shares in the last quarter. Zimmer Partners LP increased its holdings in shares of PACS Group by 191.2% in the third quarter. Zimmer Partners LP now owns 2,329,529 shares of the company’s stock valued at $93,111,000 after buying an additional 1,529,529 shares in the last quarter. FMR LLC increased its holdings in shares of PACS Group by 174.4% in the third quarter. FMR LLC now owns 1,641,651 shares of the company’s stock valued at $65,617,000 after buying an additional 1,043,399 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of PACS Group by 5.9% in the third quarter. JPMorgan Chase & Co. now owns 1,272,720 shares of the company’s stock valued at $50,871,000 after buying an additional 70,786 shares in the last quarter. Finally, Crewe Advisors LLC increased its holdings in shares of PACS Group by 66,972.9% in the fourth quarter. Crewe Advisors LLC now owns 1,112,068 shares of the company’s stock valued at $14,579,000 after buying an additional 1,110,410 shares in the last quarter.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on PACS shares. Stephens dropped their price target on PACS Group from $48.00 to $31.00 and set an “overweight” rating on the stock in a report on Monday, November 18th. Macquarie dropped their price target on shares of PACS Group from $42.00 to $24.00 and set an “outperform” rating on the stock in a research note on Monday, January 6th. Truist Financial dropped their price target on shares of PACS Group from $46.00 to $32.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $18.00 price target on shares of PACS Group in a research note on Tuesday, December 17th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $34.00.

PACS Group Price Performance

Shares of NYSE:PACS opened at $12.95 on Friday. PACS Group, Inc. has a 1 year low of $12.38 and a 1 year high of $43.92. The firm has a fifty day moving average price of $13.58 and a 200 day moving average price of $24.43. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.82.

PACS Group Company Profile

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.